S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The gold catalyst we’ve waited for (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
The gold catalyst we’ve waited for (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
The gold catalyst we’ve waited for (Ad)
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:BLFS

BioLife Solutions - BLFS Competitors

$21.53
+0.01 (+0.05%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$21.22
$21.80
50-Day Range
$19.50
$26.07
52-Week Range
$10.40
$26.96
Volume
298,192 shs
Average Volume
331,301 shs
Market Capitalization
$920.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00

BLFS vs. OM, VRAY, ZYXI, EDAP, AXGN, LIVN, TMDX, ITGR, INMD, and CNMD

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Outset Medical (OM), ViewRay (VRAY), Zynex (ZYXI), Edap Tms (EDAP), AxoGen (AXGN), LivaNova (LIVN), TransMedics Group (TMDX), Integer (ITGR), InMode (INMD), and CONMED (CNMD). These companies are all part of the "electromedical equipment" industry.

BioLife Solutions vs.

Outset Medical (NASDAQ:OM) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability, valuation and community ranking.

Outset Medical has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500.

BioLife Solutions received 280 more outperform votes than Outset Medical when rated by MarketBeat users. Likewise, 67.96% of users gave BioLife Solutions an outperform vote while only 37.78% of users gave Outset Medical an outperform vote.

CompanyUnderperformOutperform
Outset MedicalOutperform Votes
17
37.78%
Underperform Votes
28
62.22%
BioLife SolutionsOutperform Votes
297
67.96%
Underperform Votes
140
32.04%

98.8% of Outset Medical shares are owned by institutional investors. Comparatively, 89.8% of BioLife Solutions shares are owned by institutional investors. 4.0% of Outset Medical shares are owned by company insiders. Comparatively, 3.3% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

BioLife Solutions has a net margin of -85.79% compared to Outset Medical's net margin of -141.24%. BioLife Solutions' return on equity of -6.79% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical -141.24% -55.22% -40.77%
BioLife Solutions -85.79% -6.79% -5.78%

Outset Medical currently has a consensus price target of $24.50, suggesting a potential upside of 28.21%. BioLife Solutions has a consensus price target of $30.00, suggesting a potential upside of 39.34%. Given BioLife Solutions' stronger consensus rating and higher probable upside, analysts plainly believe BioLife Solutions is more favorable than Outset Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
BioLife Solutions
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, BioLife Solutions had 5 more articles in the media than Outset Medical. MarketBeat recorded 8 mentions for BioLife Solutions and 3 mentions for Outset Medical. BioLife Solutions' average media sentiment score of 0.21 beat Outset Medical's score of -0.09 indicating that BioLife Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioLife Solutions
1 Very Positive mention(s)
4 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BioLife Solutions has higher revenue and earnings than Outset Medical. BioLife Solutions is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$115.38 million8.06-$162.96 million-$3.41-5.60
BioLife Solutions$161.76 million5.69-$149.85 million-$3.26-6.60

Summary

BioLife Solutions beats Outset Medical on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$920.84M$3.38B$4.33B$5.90B
Dividend YieldN/A1.48%2.39%4.40%
P/E Ratio-6.6011.51106.3712.67
Price / Sales5.6943.163,459.4656.37
Price / CashN/A19.9127.23103.34
Price / Book2.533.124.474.95
Net Income-$149.85M$115.47M$114.81M$190.66M
7 Day Performance0.05%2.56%-0.80%0.58%
1 Month Performance-5.28%-4.69%-6.59%-5.97%
1 Year Performance-2.23%28.06%-16.47%-18.83%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OM
Outset Medical
1.1873 of 5 stars
$21.00
-4.3%
$24.50
+16.7%
-54.2%$1.02B$115.38M-6.16444
VRAY
ViewRay
2.099 of 5 stars
$3.35
-4.3%
$6.75
+101.5%
-15.2%$609.03M$102.21M-5.78267Insider Selling
ZYXI
Zynex
2.323 of 5 stars
$10.77
-3.1%
$16.83
+56.3%
+72.8%$447.28M$158.17M24.48774
EDAP
Edap Tms
1.8067 of 5 stars
$11.07
-1.4%
$12.50
+12.9%
+54.1%$400.18M$51.94M100.65223Upcoming Earnings
AXGN
AxoGen
2.0606 of 5 stars
$8.75
-1.8%
$17.00
+94.3%
+15.4%$372.75M$138.58M-12.87428
LIVN
LivaNova
2.2178 of 5 stars
$43.46
-0.5%
$76.20
+75.3%
-47.2%$2.33B$1.02B-26.832,900
TMDX
TransMedics Group
1.9315 of 5 stars
$74.31
-1.7%
$71.57
-3.7%
+202.1%$2.39B$93.46M-59.45148Positive News
ITGR
Integer
2.0646 of 5 stars
$74.16
-0.3%
$87.00
+17.3%
-1.0%$2.47B$1.38B37.4510,000
INMD
InMode
2.3675 of 5 stars
$30.48
-3.5%
$46.33
+52.0%
-25.1%$2.63B$454.27M16.04362
CNMD
CONMED
2.129 of 5 stars
$96.84
+2.6%
$120.00
+23.9%
N/A$2.95B$1.05B-34.103,800Analyst Report
News Coverage
This page (NASDAQ:BLFS) was last updated on 3/25/2023 by MarketBeat.com Staff